Xifaxa (Rifaximin) 550mg tablets are indicated for
- Hepatic Encephalopathy: for maintenance of Remission of
- Hepatic encephalopathy.
- Irritable Bowel Syndrome
- Traveler’s Diarrhea
- Surgical Antibiotic Prophylaxis
Xifaxa®550mg Tablet (Rifaximin)
Rifaximin is a broad-spectrum, FDA approved non systemic Gut targeted antibiotic with an excellent safety profile, a lack of drug interactions. Rifaximin acts by inhibition of bacterial RNA synthesis. Rifaximin is bactericidal against a broad array of enteric pathogens, including gram-positive, gram-negative, aerobic and anaerobic bacteria.
Xifaxa (Rifaximin) 550mg tablet is available in pack of 10’s tablets.
